Nectar Lifescience Ltd - NECTAR LIFESCI. Share Price

Sector: Pharmaceuticals | ISIN: INE023H01027
₹ 34.60 (1.76%) icon24 Apr, 2024, 12:00:00 AM

Nectar Lifescience Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/24/2024 12:00:00 AM

    ₹ 34.6 0.60 1.76
  • Open
  • ₹ 34.2
  • Prev. Close
  • ₹ 34
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 35.9
  • Day's Low
  • ₹ 33.75
  • 52 Week's High
  • ₹ 45.7
  • 52 Week's Low
  • ₹ 16.5
  • Book Value
  • ₹ 47.67
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 775.94
  • P/E
  • 78.48
  • EPS
  • 0.44
  • Divi. Yield
  • 0

Nectar Lifescience Ltd Corporate Actions

31 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2024

12:00 AM

03 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2023

12:00 AM

26 May , 2023

12:00 AM

AGM

Announcement date: 26 May , 2023

View Details

05 Aug , 2023

12:00 AM

05 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 May , 2023

12:00 AM

BookCloser

View Details

No Record Found


Nectar Lifescience Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Nectar Lifescience Ltd SHAREHOLDING SNAPSHOT
25 April , 2024 | 07:42 AM

PROMOTER - TOTAL44.35%

Indian: 44.35%

Foreign: 0%

NON-PROMOTER - TOTAL 35.13%

Institutions: 13.51%

Non-Institutions: 21.63%

CUSTODIES - 20.51%

Custodies: 20.51%

See More Details
ad IconAd Image

Nectar Lifescience Ltd FINANCIALS

Nectar Lifescience Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Nectar Lifescience Ltd

  • Sanjiv Goyal
  • Chairman & Managing Director
  • Ajay Swaroop
  • Independent Director
  • Meena Verma
  • Nominee
  • Rupinder Tewari
  • Independent Director
  • Anubha
  • Company Sec. & Compli. Officer
  • Kuldip Kumar Bhasin
  • Independent Director
  • Indu Pal Kaur
  • Independent Director
  • Puneet Sud
  • Director (Operation)

Summary

Nectar Lifesciences Ltd (NLL or NECLIFE) is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. The company manufactures Cephalosporin Active pharmaceutical ingredients, finished dosage forms, Phytochemicals, and hard gelatin capsules at their facilities spread across three Indian states of Punjab, Himachal Pradesh and Jammu. They have developed sustainable production systems to manufacture high quality intermediates and APIs to meet the diverse requirements of their customer base in India and over 90 countries worldwide. The companys business operations are primarily concentrated on manufacturing and marketing of oral and sterile cephalosporins, phytochemicals and allied products. They manufacture and sell a range of cephalosporins and phytochemicals. They are also engaged in contract manufacturing of APIs for pharmaceutical players.Nectar Lifesciences Ltd was incorporated on June 27, 1995 as a public limited company with the name Surya Medicare Ltd. The company was established pursuant to a financial collaboration agreement between the Promoters and Punjab State Industrial Development Corporation.In April 1997, the company commenced business with the commercial production of Oral Bulk Drugs at their manufacturing facility located in the B Category zone of Punjab. In March 1998, they started the production of Sterile Bulk Drugs. In the year 1999, they added the formulation facilities by setting up a vial... Read More


Reports by Nectar Lifescience Ltd


Reports by Nectar Lifescience Ltd

Company FAQ

No Record Found